Analysts are bullish on Adani Enterprises, HAL, and Trent, citing growth drivers like new energy and engine co-production. Aurobindo Pharma’s biologics expansion shows promise but financial gains are distant. Aditya Birla Capital’s housing finance arm impresses with strong loan growth and improved asset quality, despite minor revenue misses.